Diabetes News
Articles 11 - 20 of most recent articles
New Discovery A Step Towards Better Diabetes Treatment
In the prestigious journal Cell Metabolism Uppsala scientists are presenting new findings that shed light on the processes that determine the release of the blood sugar-lowering hormone insulin. The discovery is based on the development of image analysis methods that make possible the detailed study of events immediately inside the plasma membrane of the insulin-secreting cells.
Medical News Today – Jul 2, 2008 12:00 PM [GMT] ¦ comment?
In the prestigious journal Cell Metabolism Uppsala scientists are presenting new findings that shed light on the processes that determine the release of the blood sugar-lowering hormone insulin. The discovery is based on the development of image analysis methods that make possible the detailed study of events immediately inside the plasma membrane of the insulin-secreting cells.
Medical News Today – Jul 2, 2008 12:00 PM [GMT] ¦ comment?
Diabetic Hypoglycaemia: ESP Bioscience Announces New Journal For 2008
ESP Bioscience today announced the forthcoming launch of Diabetic Hypoglycaemia (www.hypodiab.com), an influential new online diabetes journal delivering a range of hypoglycaemia information, including: background science, human physiology, and clinical and educational communications.
Medical News Today – Jul 2, 2008 11:00 AM [GMT] ¦ comment?
ESP Bioscience today announced the forthcoming launch of Diabetic Hypoglycaemia (www.hypodiab.com), an influential new online diabetes journal delivering a range of hypoglycaemia information, including: background science, human physiology, and clinical and educational communications.
Medical News Today – Jul 2, 2008 11:00 AM [GMT] ¦ comment?
OneTouch(R) Ping(TM) Glucose Management System Cleared By FDA
Animas Corporation announced today the clearance of its OneTouch(R) Ping(TM) Glucose Management System by the U.S. Food and Drug Administration (FDA). OneTouch Ping is the first full-feature insulin pump that wirelessly communicates with a blood glucose meter-remote.
Medical News Today – Jul 2, 2008 10:00 AM [GMT] ¦ comment?
Animas Corporation announced today the clearance of its OneTouch(R) Ping(TM) Glucose Management System by the U.S. Food and Drug Administration (FDA). OneTouch Ping is the first full-feature insulin pump that wirelessly communicates with a blood glucose meter-remote.
Medical News Today – Jul 2, 2008 10:00 AM [GMT] ¦ comment?
Echo Therapeutics Initiates Clinical Study Of Its Symphony(TM) Transdermal Continuous Glucose Monitoring System In Patients With Diabetes
Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE) announced that it has initiated a clinical study of its Symphony(TM) Transdermal Continuous Glucose Monitoring System (tCGM System) in patients with Type 1 and Type 2 diabetes. The Company expects to complete and announce the results of the study in the third quarter of 2008.
Medical News Today – Jul 2, 2008 10:00 AM [GMT] ¦ comment?
Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE) announced that it has initiated a clinical study of its Symphony(TM) Transdermal Continuous Glucose Monitoring System (tCGM System) in patients with Type 1 and Type 2 diabetes. The Company expects to complete and announce the results of the study in the third quarter of 2008.
Medical News Today – Jul 2, 2008 10:00 AM [GMT] ¦ comment?
Workplace Weight Programs Produce Modest Losses
WASHINGTON (Reuters) - People who take part in weight-loss programs set up by their employers manage to lose at least modest amounts of weight compared to co-workers who do not take part, U.S.
American Diabetes Association – Jul 1, 2008 3:01 PM [GMT] ¦ comment?
WASHINGTON (Reuters) - People who take part in weight-loss programs set up by their employers manage to lose at least modest amounts of weight compared to co-workers who do not take part, U.S.
American Diabetes Association – Jul 1, 2008 3:01 PM [GMT] ¦ comment?
News From The Annals Of Internal Medicine July 1, 2008
1. Benefits of Tight Glucose Control Remain Uncertain for Older Diabetics In a computer modeling study, researchers set out to assess the effects of comorbid illnesses and functional status on the expected benefits of intensive glucose control.
Medical News Today – Jul 1, 2008 12:00 PM [GMT] ¦ comment?
1. Benefits of Tight Glucose Control Remain Uncertain for Older Diabetics In a computer modeling study, researchers set out to assess the effects of comorbid illnesses and functional status on the expected benefits of intensive glucose control.
Medical News Today – Jul 1, 2008 12:00 PM [GMT] ¦ comment?
The Underlying Molecular Mechanism For Hypertension, Insulin Resistance And Other Metabolic Complications Identified
Many of the 75 million Americans with essential hypertension also develop diabetes and other complications in addition to their high blood pressure, and researchers have discovered a common molecular mechanism in a strain of rat that explains why such metabolic disorders arise together in mammals.
Medical News Today – Jul 1, 2008 11:00 AM [GMT] ¦ comment?
Many of the 75 million Americans with essential hypertension also develop diabetes and other complications in addition to their high blood pressure, and researchers have discovered a common molecular mechanism in a strain of rat that explains why such metabolic disorders arise together in mammals.
Medical News Today – Jul 1, 2008 11:00 AM [GMT] ¦ comment?
VIVUS Announces New Data From Qnexa Diabetes Study
VIVUS, Inc. (NASDAQ: VVUS), a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products, announced additional data from the 28-week Qnexa phase 2 study (OB-202) in type 2 diabetics. A subset analysis of subjects with higher cardiovascular risk factors at baseline had significantly greater improvements on Qnexa as compared to placebo.
Medical News Today – Jul 1, 2008 07:00 AM [GMT] ¦ comment?
VIVUS, Inc. (NASDAQ: VVUS), a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products, announced additional data from the 28-week Qnexa phase 2 study (OB-202) in type 2 diabetics. A subset analysis of subjects with higher cardiovascular risk factors at baseline had significantly greater improvements on Qnexa as compared to placebo.
Medical News Today – Jul 1, 2008 07:00 AM [GMT] ¦ comment?
Link Between Starvation And Growth Hormone May Be Clue To Increasing Life Span, Researchers Find
Researchers at UT Southwestern Medical Center have determined that starvation blocks the effects of growth hormone via a mechanism that may have implications in treating diabetes and extending life span. "It's been well-established that growth is blunted during starvation. But our work shows that this is not just from running out of energy. It's much more sophisticated than that," said
Medical News Today – Jun 30, 2008 07:00 AM [GMT] ¦ comment?
Researchers at UT Southwestern Medical Center have determined that starvation blocks the effects of growth hormone via a mechanism that may have implications in treating diabetes and extending life span. "It's been well-established that growth is blunted during starvation. But our work shows that this is not just from running out of energy. It's much more sophisticated than that," said
Medical News Today – Jun 30, 2008 07:00 AM [GMT] ¦ comment?
Volunteering Opportunities For Healthcare Professionals
The Care Events team at Diabetes UK is looking for healthcare professionals to volunteer on its holidays and weekends for people with diabetes. If you have diabetes or an interest in diabetes and have the right skills and expertise that can be used on our events, we encourage you to apply.
Medical News Today – Jun 29, 2008 07:00 AM [GMT] ¦ comment?
The Care Events team at Diabetes UK is looking for healthcare professionals to volunteer on its holidays and weekends for people with diabetes. If you have diabetes or an interest in diabetes and have the right skills and expertise that can be used on our events, we encourage you to apply.
Medical News Today – Jun 29, 2008 07:00 AM [GMT] ¦ comment?
